Latest News in the pharma Industry
Research & Development
.jpg)
NousCom raises €42 million to develop off-the-shelf cancer vaccine
6 Nov 2017
Financing to advance its pipeline of neoantigen cancer-based immunotherapies to the clinic.
Read more.png)
RA patients treated with baricitinib reported greater improvements in pain compared with adalimumab
5 Nov 2017
Post-hoc analysis shows pain improvement was consistent regardless of a patient's baseline pain severity.
Read more
RedHill Biopharma and IntelGenx submit NDA to FDA for Rizaport for migraines
2 Nov 2017
Rizaport is a proprietary oral thin-film formulation of rizatriptan for the treatment of acute migraines.
Read more
Cristal Therapeutics progresses nanomedicine CriPec-docetaxel to Phase Ib development
1 Nov 2017
This nanomedicine candidate is specifically designed to enable enhanced tumour accumulation and local drug release at the target site, to boost the therapeutic efficacy and to overcome the shortfalls associated with current docetaxel products.
Read more
FDA approves AstraZeneca's Calquence for adult patients with mantle cell lymphoma
31 Oct 2017
Accelerated approval of Bruton tyrosine kinase inhibitor in MCL marks AstraZeneca's entry into the treatment of blood cancers.
Read more
NIH study identifies new targets for anti-malaria drugs
27 Oct 2017
The deadliest malaria parasite needs two proteins to infect red blood cells.
Read more.jpg)
First social-health research on the use of seawater in respiratory diseases
25 Oct 2017
7 out of 10 users preferred seawater to traditional serum, claiming it even reduces sick days.
Read more
Arch Biopartners initiates manufacturing process for Metablok
17 Oct 2017
In pre-clinical studies, Metablok has shown it has the ability to prevent acute kidney injury by blocking the inflammatory response triggered by kidney ischemia/reperfusion.
Read more
SGS and Bavarian Nordic to develop a novel and differentiated challenge model for RSV
13 Oct 2017
Project will build upon the results of Phase II trials undertaken by Bavarian Nordic.
Read more
PnuVax awarded $29.4 million grant to advance innovative vaccine into clinical trials
2 Oct 2017
Use of PnuVax’s unique patented conjugation platform technology to produce the vaccine is expected to speed up biomanufacturing and increase yield for a greatly reduced per-dose cost.
Read more
Ardena acquisition will support sponsors with bioanalytical and drug discovery services
21 Sep 2017
CDMO on target to become a one-source contract partner for early-phase development.
Read more
New service delivers streamlined pathway for Phase I trial milestones
12 Sep 2017
Whether you're a small, virtual firm or Big Pharma, Recipharm Pathway to Clinic can remove the complexity out of first in human projects.
Read more